122 related articles for article (PubMed ID: 6198119)
41. Relative susceptibility of SJL/J and B10.S mice to experimental allergic encephalomyelitis (EAE) is determined by the ability of prethymic cells in bone marrow to develop into EAE effector T cells.
Binder TA; Greiner DL; Grunnet M; Goldschneider I
J Neuroimmunol; 1993 Jan; 42(1):23-32. PubMed ID: 8093702
[TBL] [Abstract][Full Text] [Related]
42. Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions.
Lemire JM; Weigle WO
J Immunol; 1986 Nov; 137(10):3169-74. PubMed ID: 2430015
[TBL] [Abstract][Full Text] [Related]
43. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
44. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
[TBL] [Abstract][Full Text] [Related]
45. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule.
Brok HP; Uccelli A; Kerlero De Rosbo N; Bontrop RE; Roccatagliata L; de Groot NG; Capello E; Laman JD; Nicolay K; Mancardi GL; Ben-Nun A; Hart BA
J Immunol; 2000 Jul; 165(2):1093-101. PubMed ID: 10878388
[TBL] [Abstract][Full Text] [Related]
46. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein.
Satoh J; Sakai K; Endoh M; Koike F; Kunishita T; Namikawa T; Yamamura T; Tabira T
J Immunol; 1987 Jan; 138(1):179-84. PubMed ID: 3491156
[TBL] [Abstract][Full Text] [Related]
47. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
[TBL] [Abstract][Full Text] [Related]
48. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
49. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis.
Mor F; Cohen IR
J Clin Invest; 1993 Nov; 92(5):2199-206. PubMed ID: 7693759
[TBL] [Abstract][Full Text] [Related]
50. 'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis.
Zamvil SS; al-Sabbagh A; Nelson PA; Kaul D; Charles MS; Mitchell DJ; Steinman L; Weiner HL; Kuchroo VK
Pathobiology; 1994; 62(3):113-9. PubMed ID: 7524528
[TBL] [Abstract][Full Text] [Related]
51. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.
Soos JM; Hobeika AC; Butfiloski EJ; Schiffenbauer J; Johnson HM
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6082-6. PubMed ID: 7541140
[TBL] [Abstract][Full Text] [Related]
52. LPS augments adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
Hamada T; Driscoll BF; Kies MW; Alvord EC
Autoimmunity; 1989; 2(4):275-84. PubMed ID: 2485079
[TBL] [Abstract][Full Text] [Related]
53. Suppressive activity of long-term myelin basic protein-specific SJL T cell lines.
Barzaga-Gilbert ME; Skeen MJ; Chou CH; Fritz RB
J Neuroimmunol; 1989 Aug; 23(3):241-7. PubMed ID: 2473998
[TBL] [Abstract][Full Text] [Related]
54. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
Karussis DM; Slavin S; Lehmann D; Mizrachi-Koll R; Abramsky O; Ben-Nun A
J Immunol; 1992 Mar; 148(6):1693-8. PubMed ID: 1541813
[TBL] [Abstract][Full Text] [Related]
55. Antibodies against I-A and I-E determinants inhibit the activation and function of encephalitogenic T-lymphocyte lines.
Offner H; Brostoff SW; Vandenbark AA
Cell Immunol; 1986 Jul; 100(2):364-73. PubMed ID: 2428509
[TBL] [Abstract][Full Text] [Related]
56. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
57. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.
Smilek DE; Wraith DC; Hodgkinson S; Dwivedy S; Steinman L; McDevitt HO
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9633-7. PubMed ID: 1719536
[TBL] [Abstract][Full Text] [Related]
58. Cellular events in the induction of experimental allergic encephalomyelitis in rats.
Ortiz-Ortiz L; Weigle WO
J Exp Med; 1976 Sep; 144(3):604-16. PubMed ID: 60461
[TBL] [Abstract][Full Text] [Related]
59. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
Bouwer HG; Hinrichs DJ
J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
[TBL] [Abstract][Full Text] [Related]
60. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis.
Ben-Nun A; Yossefi S; Lehmann D
Eur J Immunol; 1993 Mar; 23(3):689-96. PubMed ID: 8095458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
